|
- Luminex’s Licensed Technology | Diasorin
Luminex's Licensed Technology Group, powered by proven xMAP ® Technology, delivers innovation in scientific development that unlocks breakthroughs in both applied and basic research We provide tools to deliver fast and reliable answers to complex problems through innovative multiplexing technologies that collectively impact patients health
- Luminex Corporation - Wikipedia
Luminex Corporation is a biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences Background [ edit ]
- Diasorin | Molecular Diagnostics and Immunodiagnostic Specialist
Licensed Technologies and Luminex products Product Documentation DiaSorin S p A - Share Capital €55 948 257 R E A 180729 - Fiscal Code and number of registration to Vercelli Companies Register no 13144290155
- Luminex | LMNX Stock Price, Company Overview News - Forbes
Luminex Corporation (Luminex)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries
- Luminex Corporation - AnnualReports. com
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics and life sciences industries worldwide It offers xMAP technology, an open architecture, multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading
- Luminex Headquarters Corporate Office
Luminex headquarters is located at 12212 Technology Blvd, Austin, Texas 78727, phone number 512-219-8020 Luminex Corporation Street: 12212 Technology Blvd City
- DiaSorin Announces Completion of the Acquisition of Luminex . . .
SALUGGIA, ITALY — DiaSorin S p A (“DiaSorin”; FTSE MIB: DIA) announces it has completed the acquisition of Luminex Corporation (“Luminex”; NASDAQ: LMNX) for a price of USD 37 00 per share that corresponds to a total equity value of approximately USD 1 8 billion
|
|
|